Alnylam Pharmaceuticals | ALNY - بدهی های جاری

قیمت سهام
313.41
تغییر روزانه
-3.82 -1.20%
ماهیانه
-5.77%
سالیانه
29.64%
Q1 پیش بینی
303.95




بدهی های جاری تغییر دادن تاریخ
Acadia Pharmaceuticals USD 277.11M 79.47M 2025-12
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Amgen USD 25.49B 3.7B 2025-12
Arrowhead Research USD 347.42M 151.94M 2025-12
BioCryst Pharmaceuticals USD 190.24M 13.08M 2025-09
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Incyte USD 1.52B 176.44M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
Moderna USD 1.99B 306M 2025-12
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Novartis USD 32B 286M 2025-09
PTC Therapeutics USD 968.43M 102.18M 2025-12
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sanofi EUR 28.35B 9.32B 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Takeda JPY 2.61T 470.53B 2025-12
Tectonic Therapeutic USD 9.37M 1.99M 2025-09
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12
Xencor USD 95.91M 9.42M 2025-12